SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Jul-24 4:54 PM View: | Amarin Corp Plc\uk (AMRN) | 01-Jul-24 | Payment of Exercise | 8,209 | $0.69 | $5,664.21 | (8%) 102.51K to 94.31K | |
01-Jul-24 4:54 PM View: | Amarin Corp Plc\uk (AMRN) | 01-Jul-24 | Option Exercise | 16,667 | -- | -- | 19% 85.85K to 102.51K | |
02-Feb-24 4:30 PM View: | Amarin Corp Plc\uk (AMRN) | 31-Jan-24 | Payment of Exercise | 24,552 | $1.24 | $30,444.50 | (26%) 93.48K to 68.93K | |
02-Feb-24 4:30 PM View: | Amarin Corp Plc\uk (AMRN) | 31-Jan-24 | Option Exercise | 44,933 | -- | -- | 93% 48.55K to 93.48K | |
12-Jan-24 5:27 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-24 | Payment of Exercise | 28,325 | $0.97 | $27,475.20 | (37%) 76.88K to 48.55K | |
12-Jan-24 5:27 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-24 | Option Exercise | 51,500 | -- | -- | 203% 25.38K to 76.88K | |
05-Jul-23 4:46 PM View: | Amarin Corp Plc\uk (AMRN) | 01-Jul-23 | Payment of Exercise | 8,209 | $1.19 | $9,768.71 | (24%) 33.58K to 25.38K | |
05-Jul-23 4:46 PM View: | Amarin Corp Plc\uk (AMRN) | 01-Jul-23 | Option Exercise | 16,667 | -- | -- | 99% 16.92K to 33.58K | |
22-Jun-23 5:10 PM View: | Amarin Corp Plc\uk (AMRN) | 20-Jun-23 | Payment of Exercise | 16,417 | $1.19 | $19,536.20 | (49%) 33.33K to 16.92K | |
22-Jun-23 5:10 PM View: | Amarin Corp Plc\uk (AMRN) | 20-Jun-23 | Option Exercise | 33,334 | -- | -- | 100% 0 to 33.33K | |
04-Mar-22 5:54 PM View: | Cara Therapeutics, Inc. (CARA) | 03-Mar-22 | Market Sale (Planned) | 2,044 | $11.38 | $23,260.70 | (5%) 39.85K to 37.81K | (7%) |
01-Mar-22 4:18 PM View: | Cara Therapeutics, Inc. (CARA) | 28-Feb-22 | Grant | 5,333 | $10.29 | $54,876.60 | 15% 34.52K to 39.85K | |
01-Mar-22 4:18 PM View: | Cara Therapeutics, Inc. (CARA) | 25-Feb-22 | Grant | 20,000 | -- | -- | 138% 14.52K to 34.52K | |
21-Dec-21 5:26 PM View: | Cara Therapeutics, Inc. (CARA) | 17-Dec-21 | Grant | 11,170 | -- | -- | 333% 3.35K to 14.52K | |
01-Sep-21 6:08 PM View: | Cara Therapeutics, Inc. (CARA) | 30-Aug-21 | Market Sale (Planned) | 1,982 | $14.20 | $28,144.40 | (37%) 5.33K to 3.35K | (11%) |
26-Aug-21 6:18 PM View: | Cara Therapeutics, Inc. (CARA) | 24-Aug-21 | Grant | 5,334 | -- | -- | 100% 0 to 5.33K |